In T2DM, agents such as semaglutide and tirzepatide effectively lower HbA1c levels, blood glucose levels, and body weight, outperforming conventional oral hypoglycemic agents and insulin
But theyre not meant to be a long-term solution when FDA-approved options are available
Gentler Appetite Control At sub-therapeutic amounts, retatrutide may still produce mild appetite suppression through its GLP-1 and GIP receptor activity
The market for nutrition and dietary supplements ostensibly supporting GLP-1 users is projected to more than triple from $4.1 billion in 2025 to $13 billion by 2035, according to research group Future Market Insights Inc
GIP receptor activation enhances the insulin response beyond what GLP-1 alone achieves
Pure, unflavored gelatin is almost entirely protein (about 85 to 90 percent)